AACI Update | April 2021

Headlines

AACI Launches Cancer Health Disparities Podcast

AACI Launches Cancer Health Disparities Podcast

A new podcast from AACI aims to expand the dialogue about cancer health disparities and to identify strategies to mitigate them. Accelerating Equity: Cancer Care for All is hosted by AACI President Karen E. Knudsen, MBA, PhD. Her first guest was Norman E. Sharpless, MD, director of the National Cancer Institute.

Read More

AACI Issues Statement Condemning Racism, Violence

Prompted by a recent mass shooting targeting Asian-American women, AACI issued a formal statement urging the cancer community, policymakers, and other stakeholders to address racism, discrimination, and gun violence as public health crises. In the statement, the association highlighted the responsibility of its Board of Directors, staff, and cancer center leaders to improve health outcomes for all people — not just as they relate to cancer, but in all facets of public health.

Read More

2021 AACI/CCAF Annual Meeting Shifts to Virtual Format

To prioritize the health and well-being of AACI meeting attendees, supporters, and cancer center patients, AACI's Board of Directors and the 2021 AACI/CCAF Annual Meeting Program Committee have decided not to move forward with an in-person meeting in Kansas City. Instead, the annual meeting will take place October 19-21 in a virtual format. The meeting was previously scheduled for October 17-19. 

Read More

Register Today for the 2021 AACI/AACR Virtual Hill Day

Register Today for the 2021 AACI/AACR Virtual Hill Day

Registration is now open for the 2021 AACI/AACR Hill Day, scheduled for Wednesday, June 9. The virtual advocacy day will consist of video and conference call meetings organized by Soapbox, a firm that specializes in coordinating advocacy days. Hill Day is open to all AACI and AACR members who wish to participate.

Read More

Cancer Care at Network Sites Survey Results Published

Cancer Care at Network Sites Survey Results Published

In a survey of the status of care across cancer center networks, AACI has found that many opportunities exist for such networks to increase patient satisfaction and outcomes and decrease treatment delays and risks. A report based on the survey’s findings has been published by the Journal of the National Comprehensive Cancer Network. AACI Past President Stanton L. Gerson, MD, is the lead author.

Read More

Promote Your Cancer Center With a CRI Meeting Program Ad

Promote Your Cancer Center With a CRI Meeting Program Ad

AACI invites you to promote your cancer center by purchasing an ad in the 13th Annual AACI CRI Meeting program. Slated to be held virtually July 13-15, the 2021 CRI meeting is expected to draw more than 700 clinical research office leaders, medical directors, cancer center administrators, and representatives from the National Cancer Institute and industry to discuss issues related to the conduct of cancer clinical trials at academic cancer centers.

Read More

Write Your Representatives to Support the TREAT Act

Write Your Representatives to Support the TREAT Act The Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act (S. 168/H.R. 708) is a critical, bipartisan piece of legislation that will allow any licensed health care provider in good standing to render services—including telehealth visits—in all states for the duration of the COVID-19 pandemic. AACI is asking cancer centers to reach out to their congressional delegations to urge them to co-sponsor and support the TREAT Act with a customizable advocacy letter.
 

Read More

News from the Centers

American Psychosocial Oncology Society Recognizes Work with Cancer Survivors

American Psychosocial Oncology Society Recognizes Work with Cancer Survivors
The University of Arizona Cancer Center

Outstanding professional dedication to the needs of cancer survivors and their caregivers has earned a lifetime achievement award for Terry Badger, PhD, RN, PMHCNS-BC, FAPOS, FAAN, from the American Psychosocial Oncology Society.

Read More

National Organization for Rare Disorders Honors Sicklick

National Organization for Rare Disorders Honors Sicklick
UC San Diego Moores Cancer Center

Jason Sicklick, MD, FACS, a surgical oncologist at Moores Cancer Center at UC San Diego Health, was recently announced as an award honoree by the National Organization for Rare Disorders.

Read More

Yoshida Honored for Increasing Colorectal Cancer Screenings

Yoshida Honored for Increasing Colorectal Cancer Screenings
University of Virginia Cancer Center

Cynthia M. Yoshida, MD, is one of six winners of a national award recognizing health care providers and institutions for their work to increase colorectal cancer screening rates. Dr. Yoshida is medical lead of UVA Cancer Center’s Colorectal Cancer Screening Program.

Read More

Carpten Elected Fellow of AACR Academy

USC Norris Comprehensive Cancer Center

John D. Carpten, PhD, founding chair for the Department of Translational Genomics in the Keck School of Medicine of USC, has been named to the 2021 class of fellows of the American Association for Cancer Research’s AACR Academy.

Read More

Miaskowski Recognized as Champion of Supportive Care Science

Miaskowski Recognized as Champion of Supportive Care Science
UCSF Helen Diller Family Comprehensive Cancer Center

In commemoration of the 50th Anniversary of the National Cancer Act, the National Cancer Institute's Division of Cancer Prevention honors Christine Miaskowski, RN, PhD, FAAN, as a champion and changemaker of cancer prevention, early detection, and symptom science.

Read More

Greco Named New Councilor for Association for Academic Surgery

Greco Named New Councilor for Association for Academic Surgery
Fox Chase Cancer Center, Temple Health

Stephanie Greco, MD, assistant professor in the Department of Surgical Oncology at Fox Chase Cancer Center, was recently named a new councilor for the Association for Academic Surgery.

Read More

Hampel Named to Leadership Position for National Society of Genetic Counselors

Hampel Named to Leadership Position for National Society of Genetic Counselors
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Heather Hampel, MS, LGC, has been elected secretary/treasurer-elect for the National Society of Genetic Counselors (NSGC). Her two-year term began in January 2021. Founded in 1971, the NSGC is the only professional organization that promotes the professional interests of genetic counselors.

Read More

System of Excellence Recognition for Hidden Scar Breast Cancer Surgery

UK Markey Cancer Center

UK HealthCare, home to the UK Markey Cancer Center, has officially been recognized as a System of Excellence for Hidden Scar breast cancer surgery, the highest level of Hidden Scar designation.

Read More

Researcher Gets Early Career Award

Researcher Gets Early Career Award
University of New Mexico Comprehensive Cancer Center

Ichiko Kinjyo, MD, PhD, was recently named a 2021 recipient of the Liz Tilberis Early Career Award. She was recognized for her work with Sarah Adams, MD, in exploring how a combination of a PARP-inhibitor and immunomodulation via immune checkpoint blockade can improve ovarian cancer treatment.

Read More

Nursing Team Honored With Achievement Award

Nursing Team Honored With Achievement Award
Fox Chase Cancer Center, Temple Health

A nursing team at Fox Chase Cancer Center has been honored as a recipient of the 2021 I AM Patient Safety award from the Patient Safety Authority. The third floor surgical nursing team was recognized for reaching the significant milestone of one year with no patient falls on their three south unit.

Read More

Back to News From the Centers

Researchers Receive $6 Million to Explore New Pancreatic Cancer Therapies

UCLA Jonsson Comprehensive Cancer Center

A team of researchers from the UCLA Jonsson Comprehensive Cancer Center has been awarded two research grants totaling $6 million from the National Institutes of Health to identify new ways to treat pancreatic cancer.

Read More

$4.2 Million Awarded for Breast Cancer Chemoprevention Study

$4.2 Million Awarded for Breast Cancer Chemoprevention Study
The University of Kansas Cancer Center

The University of Kansas Cancer Center researchers have received a $4.2 million grant from the National Cancer Institute to study bazedoxifene and low-dose conjugated estrogen in women who are at increased risk for developing breast cancer and are experiencing menopausal symptoms. Carol Fabian, MD, is principal investigator.

Read More

$1.47 Million Awarded to Study DNA Damage Regulation

$1.47 Million Awarded to Study DNA Damage Regulation
UAMS Winthrop P. Rockefeller Cancer Institute

A five-year, $1.47 million National Cancer Institute grant has been awarded to researcher Justin Leung, PhD, at the University of Arkansas for Medical Sciences (UAMS) to study DNA damage regulation. Dr. Leung’s project is a collaboration with Robert Eoff, PhD.

Read More

Researchers Receive PCF Challenge Award

Researchers Receive PCF Challenge Award
Sidney Kimmel Cancer Center at Jefferson Health

The Prostate Cancer Foundation (PCF) recently announced that a multi-institutional team led by Sidney Kimmel Cancer Center researcher Veda N. Giri, MD, has been awarded the 2020 Janssen-PCF Challenge Award.

Read More

Back to News From the Centers

Tackett Named Deputy Director

Tackett Named Deputy Director
UAMS Winthrop P. Rockefeller Cancer Institute

Cancer researcher Alan Tackett, PhD, has been named deputy director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS). He previously served as associate director of basic research for the UAMS Cancer Institute.

Read More

New Director of Neuro-Oncology Named

Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey has named Michael E. Salacz, MD, as director of its neuro-oncology program. He joins Rutgers from the University of Kansas Medical Center, where he directed the brain and spine tumor program.

Read More

Community Outreach and Engagement Team Expands

Community Outreach and Engagement Team Expands
Duke Cancer Institute, Duke University Medical Center

Tomi Akinyemiju, PhD, MS, has been named Duke Cancer Institute’s new associate director of community outreach and engagement. Before joining Duke in 2019 she was assistant dean for inclusive excellence at Markey Cancer Center at the University of Kentucky.

Read More

Hawley to Oversee Education, Training Programs

Hawley to Oversee Education, Training Programs
University of Michigan Rogel Cancer Center

The University of Michigan Rogel Cancer Center has named Sarah Hawley, PhD, MPH, associate director for training, education and career development. She will lead the center’s efforts to coordinate and enhance robust resources that support faculty, trainees, and students interested in cancer research.

Read More

Associate Director for Mentoring and Career Development Announced

Associate Director for Mentoring and Career Development Announced
Wilmot Cancer Institute, UR Medicine

In January, breast oncologist Ruth O’Regan, MD, officially joined the University of Rochester Medical Center from the University of Wisconsin. Now she will have significant involvement with Wilmot Cancer Institute, serving as associate director for mentoring and career development.

Read More

New Leadership Appointments

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

The Lurie Cancer Center announces several new leadership appointments, effective April 1, 2021: Marcelo Bonini, PhD, associate director for education and training; Devalingam Mahalingam, MBBCh BAO, director of the clinical trials office; and Priya Kumthekar, MD, co-chair of the scientific review committee.

Read More

Back to News From the Centers

Cracking the Case of a Deadly Type of Kidney Cancer

Cracking the Case of a Deadly Type of Kidney Cancer
Duke Cancer Institute, Duke University Medical Center

A research team led by Andrew Armstrong, MD, MSc, has identified new targets in metastatic non-clear cell renal cell carcinoma that could lead to the development of innovative therapies in this disease.

Read More

Study Finds Lower Costs, Better Outcomes in Prostate Cancer Therapy

Study Finds Lower Costs, Better Outcomes in Prostate Cancer Therapy
The University of Vermont Cancer Center

An interdisciplinary team of Vermont researchers and a partner at Yale's Smilow Cancer Center conducted an economic evaluation to establish an overall cost-effectiveness comparison of two approaches to the treatment of low-volume metastatic prostate cancer. Lead author is Nataniel Lester-Coll, MD.

Read More

Novel Drug Combo Shows Promise Against Triple-Negative Breast Cancer

Novel Drug Combo Shows Promise Against Triple-Negative Breast Cancer
City of Hope Comprehensive Cancer Center

City of Hope scientists have combined a checkpoint inhibitor with an anti-parasitic drug, ivermectin, to successfully treat triple-negative breast cancer in preclinical research, according to a new study led by Peter P. Lee, MD. (Ivermectin is also currently being used in clinical trials to treat and prevent COVID-19.)

Read More

Cancer Tricks Immune Cells, Immunotherapy Can Take Advantage

Cancer Tricks Immune Cells, Immunotherapy Can Take Advantage
UPMC Hillman Cancer Center

A study conducted by a team of scientists at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine, led by Greg Delgoffe, PhD, shows how chemicals in the tumor microenvironment subvert the immune system and enable cancer to evade attack.

Read More

Researchers Illuminate Potential Precursors of Blood Cancers

Huntsman Cancer Institute, University of Utah

Utah researchers report significant new insights into the development of blood cancers. In recently published work scientists describe an analysis of published data from more than 7,000 patients diagnosed with leukemia and other blood disorders.

Read More

Response to Cancer Immunotherapy May Be Affected by Genes We Carry From Birth

UCSF Helen Diller Family Comprehensive Cancer Center

A new study finds that inherited genetic variation plays a role in who is likely to benefit from checkpoint inhibitors. The study also points to potential new targets that could help even more patients unleash their immune systems' natural power to fight off malignant cells.

Read More

Studies Support Updated USPSTF Lung Cancer Screening Guidelines

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Two new studies published by investigators at The Ohio State University and the UNC Lineberger Comprehensive Cancer Center provide important evidence review and predictive modeling data to inform updated lung cancer screening guidelines implemented by the U.S. Preventive Services Task Force (USPSTF).

Read More

Cancer Immunotherapy Approach Targets Common Genetic Alteration

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

A new cancer immunotherapy prototype uses engineered T cells to target a genetic alteration common among all cancers. The approach, which stimulates an immune response against cells that are missing one gene copy, was developed at the Ludwig Center, Lustgarten Laboratory and the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center.

Read More

Collagen Plays Protective Role During Pancreatic Cancer Development

The University of Texas MD Anderson Cancer Center

Contrary to long-held beliefs, Type I collagen produced by cancer-associated fibroblasts may not promote cancer development but instead plays a protective role in controlling pancreatic cancer progression, reports a new study from researchers at The University of Texas MD Anderson Cancer Center. Raghu Kalluri, MD, PhD, is senior author.

Read More

Earlier Colonoscopies Reduce Subsequent Cancer Risk by Half

Stanford Cancer Institute

Stanford researchers have found that initiating colonoscopy screening between the ages of 45 and 49 halves the risk of subsequent development of colorectal cancers.

Read More

A Measure of Cleanliness

A Measure of Cleanliness
University of New Mexico Comprehensive Cancer Center

Michelle Ozbun, PhD, and her team developed a way to measure how many infectious human papillomavirus particles are left on a surface after it has been disinfected. They used sophisticated microscopic techniques developed at the UNM Comprehensive Cancer Center to count how many cells are infected and how many virus particles were present.

Read More

Marine Natural Product Discovered Off Florida Coast Could Help Fight Cancer

Marine Natural Product Discovered Off Florida Coast Could Help Fight Cancer
University of Florida Health Cancer Center

From cyanobacteria blooms found off the Florida coast near Fort Lauderdale, University of Florida researchers have discovered a novel marine natural product that binds to a new site of tubulin, an important target for cancer drugs.

Read More

Abundance of Iron Drives Cell Death, Could Be Key to Novel Neuroblastoma Treatments

VCU Massey Cancer Center

Anthony Faber, PhD, and a team of researchers at VCU Massey Cancer Center are studying how the gene MYCN and an abundance of iron can drive cancer cell death in neuroblastoma and potentially be targeted with novel treatments.

Read More

Cancer Patients Most Worried About Finances Have Worse Outcomes

Cancer Patients Most Worried About Finances Have Worse Outcomes
Roswell Park Comprehensive Cancer Center

New research from Roswell Park Comprehensive Cancer Center provides the first evidence that a cancer patient’s level of financial worry as they begin treatment predicts how likely it is that their treatment will be successful. The study's senior author is Anurag Singh, MD.

Read More

Current Liver Cancer Screenings May Leave African Americans at Greater Risk

The Tisch Cancer Institute at Mount Sinai

Mount Sinai researchers found that nearly one-third of Black patients in their study would not have qualified for liver cancer screening using common cirrhosis measures. The study also found that at the time of diagnosis, the tumors in Black patients tended to be larger, more numerous, more aggressive, and more invasive.

Read More

New Barrett's Esophagus Monitoring Method Could Aid in Easier, More Precise Prognoses

Case Comprehensive Cancer Center

A new technique for sampling and testing cells from Barrett's esophagus patients could result in earlier and easier identification of patients whose disease has progressed toward cancer or are at high risk of progressing toward cancer, according to investigators at Case Western Reserve University and Johns Hopkins Kimmel Cancer Center.

Read More

Proteomics Analysis Identifies Potential Drug Targets for Aggressive Human Cancers

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine

Historically, researchers have mostly generated transcriptomic data from cancer tissues, seeking clues about altered cellular pathways that might drive cancer behavior and represent novel therapeutic targets. While this approach has been useful, Baylor College of Medicine researchers think that transcriptomic data alone might not tell the whole story behind cancer.

Read More

Researchers Study Role of Zinc in Cancer

Researchers Study Role of Zinc in Cancer
Wilmot Cancer Institute, UR Medicine

An essential mineral used to boost the immune system and block sunburns, zinc—in a different form—can also stabilize a protein that helps to prevent most cancers, according to a Wilmot Cancer Institute study led by Darren Carpizo, MD, PhD.

Read More

Study Incorporates Genetics, Smoking History to Identify High-Risk Smokers for Lung Cancer Screening

Vanderbilt-Ingram Cancer Center

A study by Vanderbilt researchers that analyzed both smoking history and genetic risk variants for lung cancer supports modifying current guidelines to include additional smokers for lung cancer screening.

Read More

Fecal Transplant Boosts Cancer Immunotherapy

UPMC Hillman Cancer Center

Researchers at UPMC Hillman Cancer Center and the National Cancer Institute demonstrate that changing the gut microbiome can transform patients with advanced melanoma who never responded to immunotherapy—which has a failure rate of 40 percent for this type of cancer—into patients who do.

Read More

Fundamental Proteins That Guide Embryo Development Are Co-Opted by Cancer

Fred Hutchinson Cancer Research Center

Fred Hutchinson Cancer Research Center scientists have identified a new protein that provides insights into a fundamental biological process and may also lead to new cancer treatments. A second study demonstrated that cancer co-opts these unusual proteins to further its growth and development.

Read More

High Tumor Mutation Burden Predicts Immunotherapy Response in Some Cancers

The University of Texas MD Anderson Cancer Center

A high rate of genetic mutations within a tumor, known as high tumor mutation burden, was only useful for predicting clinical responses to immune checkpoint inhibitors in a subset of cancer types, according to a new study led by researchers from The University of Texas MD Anderson Cancer Center.

Read More

Multisystem Failure Regarding Frailty Necessitates Multisystem Intervention

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

Gaining a better understanding of physical frailty could eventually help people age more healthfully, suggests a Johns Hopkins research team led by Ravi Varadhan, PhD, and Linda Fried, MD, MPH.

Read More

Promising Role for Whole Genome Sequencing in Guiding Blood Cancer Treatment

Siteman Cancer Center

Whole genome sequencing is a potentially viable approach for determining the best treatment regimen for individual patients with acute myeloid leukemia or myelodysplastic syndrome, according to a new study from Washington University researchers at Siteman Cancer Center. David H. Spencer, MD, PhD, is senior author of the study.

Read More

Stopping Mutant KRAS Could Enhance Therapies for Pancreatic Cancer

Stony Brook Cancer Center

A collaborative study by Stony Brook University scientists takes an initial step toward better understanding how KRAS drives immune evasion and demonstrates a lowering of the KRAS activity resulting in a more favorable immune environment to fight cancer.

Read More

New Biomarker of Response to Checkpoint Inhibitors Identified

Roswell Park Comprehensive Cancer Center

A team of Roswell Park researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors shortly after patients with non-small cell lung cancer initiate therapy.

Read More

Therapy Sneaks Into Hard Layer of Pancreatic Cancer Tumor, Destroys From Within

UC San Diego Moores Cancer Center

Researchers at University of California San Diego School of Medicine and Moores Cancer Center, in collaboration with Sanford Burnham Prebys Medical Discovery Institute and Columbia University, have demonstrated that a new tumor-penetrating therapy, tested in animal models, may enhance the effects of chemotherapy, reduce metastasis, and increase survival.

Read More

Vital Player Identified in Graft-Versus-Host Disease and Organ Transplant Rejection

University of Michigan Rogel Cancer Center

A long noncoding RNA whose function was previously unknown turns out to play a vital role in mobilizing the immune response following a bone marrow transplant or solid organ transplantation, according to a new study by researchers at the University of Michigan Rogel Cancer Center and Michigan Medicine.

Read More

Forty-Three Percent of Melanoma Patients Have Chronic Complications From Immunotherapies

Forty-Three Percent of Melanoma Patients Have Chronic Complications From Immunotherapies
Vanderbilt-Ingram Cancer Center

Chronic side effects among melanoma survivors after treatment with anti-PD-1 immunotherapies are more common than previously recognized, according to a new study. Senior author is Douglas Johnson, MD, MSCI, clinical director of melanoma at Vanderbilt-Ingram Cancer Center.

Read More

Back to News From the Centers

First Lady Jill Biden Visits Massey to Discuss Cancer Disparities, Community Engaged Research

First Lady Jill Biden Visits Massey to Discuss Cancer Disparities, Community Engaged Research
VCU Massey Cancer Center

Jill Biden, EdD, the First Lady of the United States, met with scientists, doctors, and community leaders at Virginia Commonwealth University Massey Cancer Center to learn how they are working together to address cancer disparities. She toured several Massey labs and learned about the cutting-edge cancer research being conducted.

Read More

Virtual Human Intervention Allows for Colorectal Cancer Screening at Home

University of Florida Health Cancer Center

A new University of Florida Health intervention gives patients who qualify access to colorectal cancer screening information and tests from the comfort of their own homes. Two recent UF studies examine new ways to effectively reach patients with a new communication tool using a virtual health assistant.

Read More

Cancer Research Pioneer Jose Baselga Dies at 61

Cancer Research Pioneer Jose Baselga Dies at 61
American Association for Cancer Research

José Baselga, MD, PhD, who was a major force in the development of molecularly targeted therapies, died March 21 at age 61 from Creutzfeldt-Jakob disease. He was a past president of the American Association for Cancer Research, former chief medical officer of Memorial Sloan Kettering Cancer Center, and executive vice president for R&D oncology at AstraZeneca.

Read More

Program Develops Cancer Education Curriculum for Appalachian Schools

UK Markey Cancer Center

After conducting a study to assess the need for cancer education materials in Appalachian Kentucky, members of UK Markey Cancer Center’s Appalachian Career Training in Oncology program worked with faculty from the UK College of Education to create a three-part cancer education curriculum for middle and high school teachers in the region.

Read More

Brain Tumor Center Established

Brain Tumor Center Established
Siteman Cancer Center

Washington University School of Medicine in St. Louis and Barnes-Jewish Hospital have established the Brain Tumor Center. The multidisciplinary practice of physicians and scientists will provide leading-edge, patient-centric care for brain tumor patients while developing transformative basic, translational, and clinical research on new therapies. Albert H. Kim, MD, PhD, is inaugural director.

Read More

Reimagining Palliative Care Learning During a Pandemic

Reimagining Palliative Care Learning During a Pandemic
Stanford Cancer Institute

Kavitha Ramchandran, MD, and her team have drawn on their knowledge of both online and in-person environments to develop a virtual palliative medicine clerkship to provide Stanford medical students the training they need during the pandemic.

Read More

Community Engagement in HIV Trials Guides Equity for COVID-19 Vaccine Studies

Community Engagement in HIV Trials Guides Equity for COVID-19 Vaccine Studies
Fred Hutchinson Cancer Research Center

Last spring, as COVID-19 began to tear through American cities and was disproportionately affecting communities of color, a Fred Hutchinson Cancer Research Center scientist pivoted to the vital work of engaging these same communities in trials of coronavirus vaccines.

Read More

Back to News From the Centers

Cancer Center Jobs

Clinical Research Coordinator KU
The University of Kansas Cancer Center
Read more
Program Director Hematology and Cellular Therapeutics
The University of Kansas Cancer Center
Read more
Quality Assurance Specialist
Barbara Ann Karmanos Cancer Institute, Wayne State University
Read more
Research Nurse
Barbara Ann Karmanos Cancer Institute, Wayne State University
Read more
Senior Director, Clinical Trials Office
The University of Kansas Cancer Center
Read more
Director, Ambulatory Planning
Siteman Cancer Center
Read more
Medical Director, Cancer Clinical Trials Office
Cedars-Sinai Cancer
Read more
Program Co-Leader, Cancer Biology
VCU Massey Cancer Center
Read more
Program Co-Leader, Cancer Prevention & Control
VCU Massey Cancer Center
Read more
Program Co-Leader, Developmental Therapeutics
VCU Massey Cancer Center
Read more
Research Scientists, Cancer Prevention and Control, Health Equity and Lifestyle Programs
Cedars-Sinai Cancer
Read more
Clinical Research Nurse
Georgetown Lombardi Comprehensive Cancer Center
Read more
Clinical Research Coordinator II
Barbara Ann Karmanos Cancer Institute, Wayne State University
Read more
Director, Clinical Research
Sidney Kimmel Cancer Center at Jefferson Health
Read more
Director, Ginny L. Clements Breast Cancer Research Institute
The University of Arizona Cancer Center
Read more
Cancer Center Bioinformatics Faculty
Sanford Burnham Prebys Medical Discovery Institute
Read more
Cancer Clinical Research Coordinator 2
Stanford Cancer Institute
Read more
Cancer Center Research Operations Administrator
Mayo Clinic Cancer Center
Read more
Clinical Research Coordinator I
Fred Hutchinson Cancer Research Center
Read more
Research Technician
The University of Arizona Cancer Center
Read more
Administrative Specialist, Research to Cancer Center Director
Sanford Burnham Prebys Medical Discovery Institute
Read more
Associate Director Administration, Cancer Center
Sanford Burnham Prebys Medical Discovery Institute
Read more
Associate Director, Clinical Research Operations
Stanford Cancer Institute
Read more
Director of Cancer Immune Monitoring Core / Assistant Professor (Research Track)
Simmons Comprehensive Cancer Center, UT Southwestern Medical Center
Read more
Regulatory Startup Project Coordinator
Moffitt Cancer Center
Read more
Associate Director for Administration
The University of Chicago Medicine Comprehensive Cancer Center
Read more
Post Doctoral Position in Hematological Malignancies
Siteman Cancer Center
Read more
Senior Scientist Position in Hematological Immunotherapeutics
Siteman Cancer Center
Read more
Associate Director for Population Sciences
Penn State Cancer Institute
Read more

Meeting Announcements

Cancer Center Survivorship Research Forum

April 15, 2021
Virtual Meeting - Masonic Cancer Center, University of Minnesota

In the past decade, cancer survivorship has matured into its own cancer discipline addressing the complex and changing needs of the growing population of cancer survivors, which now exceeds 17 million individuals in the United States alone. Cancer survivorship care requires innovative collaboration among experts from multiple healthcare disciplines.

During this two-day virtual symposium on the needs and care for cancer survivors, attendees will hear from clinicians and researchers on the ongoing chronic conditions of cancer survivors, areas of research, as well as ways to improve clinical care.

This symposium will address the entire spectrum of cancer survivorship care: monitoring and management of the late and long term effects ranging from cardiotoxicity to cognitive changes, screening for other malignancies, and promotion of healthy lifestyles.

The event is intended for researchers in epidemiology and medicine who conduct research in the area of cancer survivorship. Additionally, it is intended for primary care providers and medical specialists who are interested in learning more about the ongoing needs of cancer survivors.

Learn More

Timing for Transplantation Consultation Guidelines: Implications to Your Practice

April 15, 2021
12:00 PM - 1:00 PM
Webinar

There is a narrow window of opportunity to proceed to hematopoietic cell transplant (HCT) for many patients. Delays may preclude transplant or impair patient outcomes. That’s what makes HCT consultation timing so important. And why the National Marrow Donor Program® (NMDP)/Be The Match® and the American Society for Transplantation and Cellular Therapy (ASTCT) jointly develop and release HCT Consultation Timing Guidelines for community hematologists/oncologists. On Thursday, April 15, at 11:00 am central time (12:00 pm eastern), join experts from the NMDP/Be The Match and ASTCT for an interactive discussion on the 2021 release of the guidelines and the implications for your practice.  

The panelists will explore: 
  • What has changed in the 2021 guidelines and how it could impact your practice 
  • How early HCT referral is a critical factor for optimal patient outcomes 
  • The expansion of age guidelines, which allows more older adults to safely undergo HCT  
  • How to use the guidelines in your practice 
Learn More
Back to top